Form D — Superluminal Medicines, Inc.
0001989478-26-000001 · filed Sep 3, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $65,480,796
- Total sold
- $65,480,796
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Superluminal Medicines, Inc.
- CIK
- 1989478
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 15 NECCO ST.
BOSTON, MA 02110 - Phone
- (301) 525-8752
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
CONY D'CRUZ · Executive OfficerBOSTON, MA Find on LinkedIn ↗
-
NANDITA SHANGARI · DirectorBOSTON, MA Find on LinkedIn ↗
-
DYLAN MORRIS · DirectorBOSTON, MA Find on LinkedIn ↗
-
DIAMANTIS XYLAS · DirectorBOSTON, MA Find on LinkedIn ↗
-
HARSHA PALADUGU · DirectorBOSTON, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗